Thyrocare Technologies (NSE:THYROCARE) Dividend Payout Ratio: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:THYROCARE Thyrocare Technologies Ltd NSE:THYROCARE
88 GF Score
Price ₹520.60
GF Value ₹396.26
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Thyrocare Technologies Dividend Payout Ratio?

Thyrocare Technologies NSE:THYROCARE -1.26% 88 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates NSE:THYROCARE with a GF Score™ of 88/100 and a GF Value™ of ₹396.26 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 54 Medical Diagnostics & Research companies, Thyrocare Technologies ranks worse than 68.52% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Thyrocare Technologies's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Thyrocare Technologies Ltd is 0.88, which seems too high.

The historical rank and industry rank for Thyrocare Technologies's Dividend Payout Ratio or its related term are showing as below:

NSE:THYROCARE' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.33   Med: 0.79   Max: 1.59
Current: 0.88

During the past 13 years, the highest Dividend Payout Ratio of Thyrocare Technologies was 1.59. The lowest was 0.33. And the median was 0.79.

NSE:THYROCARE's Dividend Payout Ratio is ranked worse than
68.52% of 54 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.49 vs NSE:THYROCARE: 0.88

As of today (2026-07-18), the Dividend Yield % of Thyrocare Technologies is 3.10%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Thyrocare Technologies was 5.05%. The lowest was 0.34%. And the median was 1.87%.

Thyrocare Technologies's Dividends per Share for the months ended in Mar. 2026 was ₹0.00.

During the past 12 months, Thyrocare Technologies's average Dividends Per Share Growth Rate was 55.60% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 23.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 18.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Thyrocare Technologies was 49.40% per year. The lowest was -15.70% per year. And the median was 21.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Thyrocare Technologies (NSE:THYROCARE) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Thyrocare Technologies Dividend Payout Ratio Related Terms

Thyrocare Technologies Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Thyrocare Technologies's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thyrocare Technologies Dividend Payout Ratio Chart

Thyrocare Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 1.32 1.42 1.11 0.94

Thyrocare Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 2.33 1.10 0.00

NSE:THYROCARE vs TMO, DHR, IDXX: Dividend Payout Ratio Comparison

For the Diagnostics & Research subindustry, Thyrocare Technologies's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thyrocare Technologies Dividend Payout Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's Dividend Payout Ratio falls into.


NSE:THYROCARE
88GF Score
Thyrocare Technologies Ltd NSE:THYROCARE
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thyrocare Technologies Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Thyrocare Technologies's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2026 )/ EPS without NRI (A: Mar. 2026 )
=9.333/ 9.944
=0.94

Thyrocare Technologies's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ 2.98
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Thyrocare Technologies (NSE:THYROCARE) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Thyrocare Technologies and its competitors. Over the past decade, Thyrocare Technologies' Dividend Payout Ratio has ranged from 0.33 to 1.59. According to the industry distribution chart, Thyrocare Technologies ranks #37 out of 54 companies in the Medical Diagnostics & Research industry, placing it in the top 68.5%.
Is Thyrocare Technologies' Dividend Payout Ratio too high?
Thyrocare Technologies' current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 1.59. Based on the distribution chart, Thyrocare Technologies ranks #37 out of 54 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Thyrocare Technologies has a GF Score™ of 88/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Thyrocare Technologies' Dividend Payout Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Thyrocare Technologies ranks #37 out of 54 companies for Dividend Payout Ratio. This places Thyrocare Technologies in the lower half of its industry. The industry median Dividend Payout Ratio is 0.49. Historically, Thyrocare Technologies' own Dividend Payout Ratio has ranged from 0.33 to 1.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Diagnostics & Research company?
The median Dividend Payout Ratio among Medical Diagnostics & Research companies is 0.49, based on 54 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Thyrocare Technologies and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Payout Ratio is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thyrocare Technologies's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thyrocare Technologies stock overvalued right now?
Based on GuruFocus' analysis, Thyrocare Technologies (NSE:THYROCARE) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹396.26, compared to a current price of ₹520.60 — trading 31.4% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Thyrocare Technologies' overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Thyrocare Technologies (NSE:THYROCARE), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thyrocare Technologies (NSE:THYROCARE) Overvalued in 2026?

Based on GuruFocus' analysis, Thyrocare Technologies stock appears to be overvalued. The current stock price of ₹520.60 is trading 31.4% above its estimated GF Value™ of ₹396.26. GuruFocus considers Thyrocare Technologies to be Significantly Overvalued.

Key valuation signals for NSE:THYROCARE:

  • Dividend Payout Ratio: 0.00
  • GF Value™: ₹396.26 vs. price of ₹520.60 (31.4% above fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the NSE:THYROCARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Thyrocare Technologies Business Description

Other Exchanges 539871:India
Address D-37/3, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others: Sale of testing equipment and consumables. The Diagnostic Testing Services segment provides Diagnostic and testing services, selling of consumables used for the collection and promotion of the pathology segment. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates Diagnostic and imaging services, selling of radio-pharmaceuticals, and selling of consumables for reporting. The Other business segment is engaged in the selling of glucometers and glucostrips under the brand name Sugarscan. The company earns the vast majority of its revenue in India.
88GF Score

Get the complete analysis for NSE:THYROCARE

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹520.60
Price
₹396.26
GF Value